Drugmakers, distributors face deluge of opioid lawsuits in the US
Society is grappling with the economic impact of a prescription drug epidemic that has led to nearly 180,000 overdose deaths from 2000 to 2015
Washington
THE companies that manufacture and distribute highly addictive painkillers are facing a barrage of lawsuits for the toll their products have taken on communities across the country as the worst drug epidemic in US history continues to escalate.
Within the past year, at least 25 states, cities and counties have filed civil cases against manufacturers, distributors and large pharmaceutical chains that make up the US$13 billion-a-year opioid industry. In the past few weeks alone, the attorneys-general for Ohio and Missouri, along with the district attorneys for three counties in Tennessee, filed suits against the industry - and the attorney-general for Oklahoma filed suit on Friday.
The strategy echoes the effort against major tobacco companies in the 1990s and is born of similar frustration over rising death rates and the increasing costs of addressing the continuing public health crisis. After years of government and pharmaceutical firms failing to control the problem, some lawyers say the suits have the potential to force the industry to curb practices that contribute to …
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Gazelle Ventures makes cash offer for No Signboard shares at S$0.0021 apiece
P&G raises annual core profit forecast on resilient demand, price hikes
Cordlife calls for trading halt after shares sink to all-time low, pending announcement
Marina Bay Sands Q1 profit surges 51.5% to US$597 million on tourism boom
Swiss watch exports plunge as China and Hong Kong demand dries up
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO